Page 129 - Apollo Book complete

• Development of early diagnostic panel for Collaboration with Manitoba Chemosensory Biology
identifying diagnostic nephropathy Group (University of Manitoba)

• Development of companion diagnostic for This collaboration is aimed at developing salivary
Mithramycin drug in gliomas exosome protocols for detecting bitter receptors – G-
protein-coupled receptors (GPCR) in pathological
• Development of exosomal curcumin from milk conditions.
exosomes
Collaboration with Ncare Solutions
• Development of fruit exosomes as drug delivery
A master research collaboration agreement was
vehicle
signed with Ncare. Ncare and AHERF are working to
develop dendritic cell vaccine/ dexosomes.
• Development of exosomal dendritic cell vaccine
Guru Nanak Institutions
Extra Mural Grants Received
AHERF has undertaken a retrospective study in
• Successfully secured Department of Biotechnology collaboration with Guru Nanak Institutions in the field
(DBT) grant in collaboration with Apollo Medical of Medical Imaging. The study is aimed at clinical
College for Identification of pharmacogenomics validation of image fusion protocol. Image fusion
determinants causing toxicity in paediatric ALL. protocols, enable better tissue discrimination.
Currently, the data is being analyzed for validating the
• Successfully secured grant by Novartis for algorithm developed by Guru Nanak Institutions.
development of urinary exosomal diagnostics.
Collaboration with CSIR-IICT, Hyderabad
• Secured BIG grant for development of Alzheimer
With this collaboration, AHERF and CSIR-IICT aim to
diagnostics.
develop:
• Secured BIG grant for development of salivary • Exosome and exosome mimetic drug delivery
exosome diagnostics. systems

• Prime Minister's Research Fellowship was granted • Dendritic cell-based vaccine
to a research scholar working at CMBRC
Collaboration with Mitra Biotech
Collaborations
Mitra Biotech, a midsized biotechnology firm offering
personalized chemosensitivity assay based on tumors
Collaboration with University of Hyderabad (UoH)
response to oncology drugs invitro. The major aims of
the collaboration are two-folds:
A memorandum of Undertaking (MOU) has been
signed between UoH and AHERF. The MOU would • Develop and enhance Mitra Biotech "CanScript"
facilitate in conducting collaborative research assay with exosome platform
activities, epidemiological and population studies,
interventional studies, clinical trials, health systems • Repurpose old drugs for new oncology applications
research, patient safety and healthcare quality. using MitrasCanScript and AHERF exosome
Conduct of conferences and workshops would enable platform
exchange programs between various disciplines.

128